Robert R. Chai-Onn

2013

In 2013, Robert R. Chai-Onn earned a total compensation of $12M as Executive Vice President, General Counsel and Chief Legal Officer Head of Corporate and Business Development at Valeant Pharmaceuticals International, a 618% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,344,844
Option Awards$9,351,000
Salary$750,000
Stock Awards$568,717
Other$6,765
Total$12,021,326

Chai-Onn received $9.4M in option awards, accounting for 78% of the total pay in 2013.

Chai-Onn also received $1.3M in non-equity incentive plan, $750K in salary, $568.7K in stock awards and $6.8K in other compensation.

Rankings

In 2013, Robert R. Chai-Onn's compensation ranked 275th out of 12,286 executives tracked by ExecPay. In other words, Chai-Onn earned more than 97.8% of executives.

ClassificationRankingPercentile
All
275
out of 12,286
98th
Division
Manufacturing
84
out of 4,614
98th
Major group
Chemicals And Allied Products
24
out of 1,466
98th
Industry group
Drugs
16
out of 1,160
99th
Industry
Pharmaceutical Preparations
14
out of 890
98th
Source: SEC filing on April 9, 2015.

Chai-Onn's colleagues

We found seven more compensation records of executives who worked with Robert R. Chai-Onn at Valeant Pharmaceuticals International in 2013.

2013

Laizer Kornwasser

Valeant Pharmaceuticals International

Group Chairman

2013

Daniel Wechsler

Valeant Pharmaceuticals International

Group Chairman

2013

J Pearson

Valeant Pharmaceuticals International

Chief Executive Officer

2013

Howard Schiller

Valeant Pharmaceuticals International

Chief Financial Officer

2013

Debora Jorn

Valeant Pharmaceuticals International

Group Chairman

2013

Brian Stolz

Valeant Pharmaceuticals International

Senior Vice President and General Manager

2013

Pavel Mirovsky

Valeant Pharmaceuticals International

President and General Manager, Europe

In-depth

You may also like